
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Biopol Chemicals Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.

Price Band
₹108
Per Share
Lot Size
1200 Shares

Minimum Investment
₹1,29,600

Issue Size
₹31.26 Cr

Face Value
₹10
Per Share
IPO Type
Book Building - SME

Retail Quota
35.08%

QIB Quota
25.02%

NII Quota
39.9%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
89.88%
Promoter Holding (Post-Issue)
65.81%
Issue Type
Book Building - SME
ISIN
INE0XW001014
Our Company is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Our product portfolio consists of 66 products which comprises of 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products and 6 polyelectrolyte products. These products are used in applications across various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals.
Covering more than 80,000 commercial products, India's chemical industry is extremely diversified and can be broadly classified into bulk chemicals, specialty chemicals, agrochemicals, petrochemicals, polymers, and fertilisers. India is the 6th largest producer of chemicals in the world and 3rd in Asia, contributing 7% to India's GDP. India's chemical sector, which was estimated to be worth around Rs. 21,50,750 crore (US$ 250 billion) in 2024, is anticipated to grow to US$ 300 billion by 2025 and Rs. 86,03,000 (US$ 1 trillion) by 2040. This industry remains an active hub of opportunities, even in an environment of global uncertainty.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offer of up to 28,94,400 equity shares of face value of Rs.10/- each (the "Equity Shares") of Biopol Chemicals Limited ("the Company" or "Biopol" or "the Issuer") for cash at a price of Rs. 108 per equity share including a share premium of Rs. 98 per equity share (the "Issue Price") aggregating to Rs. 31.26 crores ("the Issue"), of which up to 1,51,200 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 108 per equity share including a share premium of Rs. 98 per equity share aggregating to Rs. 1.63 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e., net issue of up to 27,43,200 equity shares of face value of Rs. 10/- each at a price of Rs. 108 per equity share including a share premium of Rs. 98 per equity share aggregating to Rs. 29.63 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.79% and 25.39% respectively of the post issue paid up equity share capital of the company. The company, in consultation with the brlm, may consider issuing 3,50,400 equity shares as a pre-ipo placement by the company for an aggregate amount up to Rs. [*]. The pre-ipo placement, if undertaken, will be at a price to be decided by the company in consultation with the brlm. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. the pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue and the proceeds of the pre-ipo placement shall be utilized towards general corporate purposes proceeds. prior to the completion of the issue, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the issue or the issue may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). Price Band: Rs. 108 per equity share of face value Rs.10/- each. The floor price is 10.8 times of the face value of the equity shares. Bids can be made for a minimum of 2,400 equity shares and in multiples of 1,200 equity shares thereafter.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Our Company was originally incorporated on April 12, 2023 under the name "Biopol Chemicals Private Limited" under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre. Subsequently, our Company acquired the sole proprietorship firm of Mr. Santanu Sarkar i.e. "United Chemical Company", pursuant to a Business Takeover Agreement dated September 25, 2023, effective from September 30, 2023. Thereafter, the status of the Company was changed to public limited Company and the name of our Company was changed to "Biopol Chemicals Limited" vide Special Resolution passed by the Shareholders at the Extra-Ordinary General Meeting of our Company held on February 22, 2024. The fresh certificate of incorporation consequent to conversion was issued on May 16, 2024 by Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U20297GJ2023PLC140117.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.
*Subject to approvals and market conditions.